Integer (NYSE:ITGR) Insider Sells 19,773 Shares

Integer Holdings Corporation (NYSE:ITGR) insider Kirk Thor sold 19,773 shares of Integer stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $126.25, for a total value of $2,496,341.25. Following the completion of the transaction, the insider directly owned 18,920 shares of the company’s stock, valued at approximately $2,388,650. This represents a 51.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Integer Stock Up 0.0%

ITGR stock traded up $0.01 during trading on Wednesday, hitting $126.22. 1,124,095 shares of the stock traded hands, compared to its average volume of 707,592. The stock has a market cap of $4.29 billion, a price-to-earnings ratio of 34.49, a price-to-earnings-growth ratio of 2.40 and a beta of 0.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $126.79. The firm’s 50 day moving average is $116.25 and its two-hundred day moving average is $98.19.

Integer (NYSE:ITGR) last issued its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm had revenue of $464.11 million for the quarter, compared to the consensus estimate of $451.07 million. During the same quarter in the prior year, the firm posted $1.55 earnings per share. The business’s revenue was down 2.6% on a year-over-year basis. On average, sell-side analysts anticipate that Integer Holdings Corporation will post 6.09 EPS for the current year.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ITGR. HBK Investments L P bought a new position in shares of Integer during the second quarter worth $14,502,000. Sequoia Financial Advisors LLC lifted its stake in Integer by 4.7% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,180 shares of the medical equipment provider’s stock worth $297,000 after purchasing an additional 142 shares in the last quarter. Corient Private Wealth LP boosted its holdings in shares of Integer by 10.7% during the 2nd quarter. Corient Private Wealth LP now owns 48,981 shares of the medical equipment provider’s stock valued at $4,577,000 after purchasing an additional 4,742 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Integer during the second quarter valued at about $215,000. Finally, Bluefin Capital Management LLC grew its position in shares of Integer by 263.6% during the second quarter. Bluefin Capital Management LLC now owns 30,332 shares of the medical equipment provider’s stock valued at $2,835,000 after purchasing an additional 21,990 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Benchmark lowered shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. Citigroup raised their price objective on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Piper Sandler cut shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 target price for the company. in a report on Monday, August 3rd. Raymond James Financial downgraded shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday, August 3rd. Finally, KeyCorp cut shares of Integer from an “overweight” rating to a “sector weight” rating in a research note on Monday, August 3rd. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Integer has a consensus rating of “Hold” and an average price target of $109.86.

Integer Company Profile

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.